Lori J. Braender, General Counsel at Aquestive Therapeutics, Inc. (AQST), bought 1,000 shares at $10.57 ($11K) on 2018-11-27, disclosed to the SEC on 2018-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AQST | BUY | 2020-03-18 | $22K | — | Filing → |
| AQST | BUY | 2019-08-13 | $41K | — | Filing → |